North America Microfluidics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Microfluidic helps to deal with the manipulation, behaviour and quick control of fluids with dimensions from ten to hundreds of micrometres. Microfluidics is used in various fields such as nanotechnology and biotechnology where low volume fluids are to be controlled to achieve multiplexing, automation and some others.

North America Microfluidics Market Segments Size & Growth:

North America Microfluidics Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by demand for point of care testing and approval for personalised medicine. Though, complex regulatory approval process hampers the growth of the North America Microfluidics market.

North America Microfluidics Market Segments Share:

North America Microfluidics market is categorised into by material which consists polymer-based, glass-based, silicon-based, and some others. Polymer-based Microfluidics is expected to grow at a quick pace due to high reliability and increasing application in various diagnostic fields. By components, it is classified by microchips, micropumps, microfluidics cartridges and reagents, micronozzles, microvalves, and so on. Microfluidics cartridges & reagents are the leading markets owing to the high usage of cartridges and reagents in laboratories. In-Vitro diagnostics is projected to have the highest growth among other application due to the rising demand for point of care testing in the healthcare sector. By end-user, it is segmented as pharmaceutical, academic & research, diagnostic lab, drug delivery services and some others. Pharmaceutical is projected to have a significant growth because of the demand for point of care and helps to monitor cancer as well as cardiovascular disorders. By Geography, U.S. is dominating the growth of the North America Microfluidics market and the growth in North America is mainly attributed because of huge insurance schemes for lab testing and medical reimbursements. Furthermore, Mexico is witnessing the fastest growth during the forecast period, due to increase in R&D and rise in healthcare expenditure.

North America Microfluidics Market Segments Trends:

• In January 2018, Roche has launched Cobas plasma separation card for real-time monitoring of HIV patients.
• In September 2017, PerkinElmer, Inc. has launched new MD system QSight 210 for clinical laboratories to provide better results.

North America Microfluidics Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Danaher Corporation
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Becton, Dickinson, And Company
• Cepheid